Diagnostic Medical Systems S.A. (ENXTPA:DGM) announced a private placement of ORNANE non convertible debt for gross proceeds of €25,000,000 on May 14, 2018. The transaction will include participation from Luxembourg fund European High Growth Opportunities Securitization Fund. The company will also issue warrants in the transaction. The warrants will have an exercise period of five years. The operation could result in a maximum contribution of € 37,500,000 of which, €25,000,000 corresponding to the subscription of all ORNANEs, and €12,500,000 corresponding to the exercise of all warrants.